出典: meddic



WordNet   license wordnet

「an oral beta blocker (trade name Tenormin) used in treating hypertension and angina; has adverse side effects (depression and exacerbation of congestive heart failure etc.)」

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/04/27 09:43:48」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Simultaneous determination of binary mixture of amlodipine besylate and atenolol based on dual wavelengths.
  • Lamie NT1.
  • Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.Spectrochim Acta A Mol Biomol Spectrosc.2015 Oct 5;149:201-7. doi: 10.1016/j.saa.2015.04.077. Epub 2015 Apr 30.
  • Four, accurate, precise, and sensitive spectrophotometric methods are developed for simultaneous determination of a binary mixture of amlodipine besylate (AM) and atenolol (AT). AM is determined at its λmax 360nm ((0)D), while atenolol can be determined by four different methods. Method (A) is abso
  • PMID 25958126
  • Charge-transfer complexes of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone with amino molecules in polar solvents.
  • Berto S1, Chiavazza E2, Ribotta V1, Daniele PG1, Barolo C3, Giacomino A4, Vione D1, Malandrino M1.
  • Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.Spectrochim Acta A Mol Biomol Spectrosc.2015 Oct 5;149:75-82. doi: 10.1016/j.saa.2015.04.044. Epub 2015 Apr 25.
  • The charge-transfer complexes have scientific relevance because this type of molecular interaction is at the basis of the activity of pharmacological compounds and because the absorption bands of the complexes can be used for the quantification of electron donor molecules. This work aims to assess t
  • PMID 25942088
  • Combination of UV absorbance and electron donating capacity to assess degradation of micropollutants and formation of bromate during ozonation of wastewater effluents.
  • Chon K1, Salhi E2, von Gunten U3.
  • Water research.Water Res.2015 Sep 15;81:388-97. doi: 10.1016/j.watres.2015.05.039. Epub 2015 May 21.
  • In this study, the changes in UV absorbance at 254 nm (UVA254) and electron donating capacity (EDC) were investigated as surrogate indicators for assessing removal of micropollutants and bromate formation during ozonation of wastewater effluents. To measure the EDC, a novel method based on size exc
  • PMID 26140990


  • β1-adrenergic receptor gene polymorphisms and the acute response to atenolol in healthy young Japanese subjects
  • Sasaguri Toshiyuki,Shiraishi Fumie,Yoshihara Tatsuya [他]
  • Journal of pharmacological sciences 115(4), 490-499, 2011-04
  • NAID 40018766384
  • Possible Involvement of β1 Receptors in Various Emetogen-Induced Increases in Salivary Amylase Activity in Rats
  • Fukui Hideo,Suyama Yoshimi,Iwachido Takako [他],Miwa Eri
  • Journal of Pharmacological Sciences advpub(0), 1012130486, 2010
  • … Isoprenaline (0.01 mg/kg, s.c.) produced an increase in salivary amylase and the increase was inhibited by the β1/2-AR antagonist propranolol (5 mg/kg, s.c.) and β1-AR antagonist atenolol (2 mg/kg, s.c.) but not by the β2-AR antagonist butoxamine (8 mg/kg, s.c.). … The increased amylase activity induced by cisplatin (15 mg/kg, i.v.), apomorphine (3 mg/kg, s.c.), or LiCl (120 mg/kg, i.p.) was inhibited significantly by atenolol (2 mg/kg, s.c.) but not by butoxamine (8 mg/kg, s.c.). …
  • NAID 130000439925


薬理学及び徴候 Atenolol が心循環器疾患をのような扱うのに使用することができる 高血圧、 冠状心臓病、 不整脈、 そして処置の 心筋梗塞 激しいでき事の後。 償われるの患者 充血性の心不全 comedication としてAtenolol と扱われるかもし ...
Atenolol comes as a tablet to take by mouth. It is usually taken once or twice a day. To help you remember to take atenolol, take it around the same time every day. Follow the directions on your prescription label ...


Atenolol for Dogs and Cats - Heart Laboratorios Lisan - AtenololAtenolol Side Effects - Learn the common Laboratorios Lisan - Atenolol Things to Remember Whe n Taking AtenololATENOLOL




アテネミールアテノリズムアルセノールアルマイラーカテノミンクシセミンセーブテンスセーラジールテネミールテノーミン Tenorminテノミロールトーワミンミロベクトメゾルミンメチニンリスモリース
アドレナリン受容体ビソプロロール メインテート不整脈用剤

  • β1選択性β遮断薬。


  • 心臓のβ1受容体を選択的に阻害。


  • 本態性高血圧症、狭心症、頻脈性不整脈(洞性頻脈、期外収縮)